Expanding Naloxone Access
Fighting the opioid crisis requires a comprehensive, sustainable approach and we believe that everyone can play an important part in charting a better path forward for victims, families, and communities across the country. The Clinton Foundation works to bring together diverse groups of stakeholders to implement solutions aimed at reversing the crisis and increasing access to naloxone and other lifesaving resources by expanding our work with schools, faith leaders, employers, and insurers.
In 2015 and 2016, the Clinton Foundation negotiated innovative agreements with Kaléo and Adapt Pharma, respectively, to decrease cost and increase access to both injectable and nasal spray forms of naloxone, an opioid overdose antidote. These partnerships made naloxone available at a discounted price to colleges and universities, public safety organizations, and community organizations.
Through its partnership with Adapt Pharma, NARCAN (naloxone in spray form) is available to high schools, colleges, and universities at no cost. Through a partnership that was launched with Direct Relief in 2019, doses of naloxone have been donated to sober living homes, public health departments and harm reduction organizations in ten U.S. states.